Talk:Extrapyramidal symptoms: Difference between revisions
>Alfie No edit summary |
>Alfie |
||
Line 15: | Line 15: | ||
==Treatment== | ==Treatment== | ||
Anticholinergic drugs are used to control neuroleptic-induced EPS, although akathisia may require beta blockers or even [[benzodiazepines]]. If the EPS are induced by an [[antipsychotic]], EPS may be reduced by dose [[Tapering|titration]] or by switching to an atypical antipsychotic, such as aripiprazole, ziprasidone, [[quetiapine]], olanzapine, [[risperidone]], or clozapine. | Anticholinergic drugs are used to control neuroleptic-induced EPS, although akathisia may require beta blockers or even [[benzodiazepines]]. If the EPS are induced by an [[antipsychotic]], EPS may be reduced by dose [[Tapering|titration]] or by switching to an atypical [[antipsychotic]], such as aripiprazole, ziprasidone, [[quetiapine]], olanzapine, [[risperidone]], or clozapine. | ||
Commonly used medications for EPS are anticholinergic agents such as benztropine (Cogentin), [[diphenhydramine]] (Benadryl), and trihexyphenidyl (Artane). Another common course of treatment includes [[dopamine]] [[agonist]] agents such as pramipexole. These medications reverse the symptoms of extrapyramidal side effects caused by antipsychotics or other drugs that either directly or indirectly inhibit [[Dopamine|dopaminergic]] neurotransmission. | Commonly used medications for EPS are anticholinergic agents such as benztropine (Cogentin), [[diphenhydramine]] (Benadryl), and trihexyphenidyl (Artane). Another common course of treatment includes [[dopamine]] [[agonist]] agents such as pramipexole. These medications reverse the symptoms of extrapyramidal side effects caused by antipsychotics or other drugs that either directly or indirectly inhibit [[Dopamine|dopaminergic]] neurotransmission. |